Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
12.13
+0.37 (3.10%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $663.00 million as of April 17, 2025.
Market Cap
663.00M
Enterprise Value
174.03M
1-Year Change
n/a
Ranking
Category
Stock Price
12.13
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has decreased from $931.70M to $663.00M, a decrease of -28.84%. That is a compound annual growth rate of -43.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2025 | 641.19M | -32.36% |
| Dec 31, 2024 | 947.92M | 1.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.93B |
| UnitedHealth Group | 535.14B |
| Johnson & Johnson | 370.90B |
| AbbVie | 303.70B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 224.94B |
| AstraZeneca | 210.38B |
| Novartis AG | 210.23B |